Ferring Pharmaceuticals Inc. has asked a New York federal court to exclude the testimony of the former head of the U.S. Patent and Trademark Office, saying it would be a “waste of time” in a patent case involving medication meant to help regulate fluid balance in the body…
Read this piece in its entirety at Law360.
